Free Access
Issue
Med Sci (Paris)
Volume 31, Number 8-9, Août–Septembre 2015
Page(s) 709 - 712
Section Nouvelles
DOI https://doi.org/10.1051/medsci/20153108002
Published online 04 September 2015
  1. Torre LA, Bray F, Siegel RF, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015 ; 65 : 87–108. [CrossRef] [PubMed] [Google Scholar]
  2. Samadder NJ, Curtin K, Tuohy TM, et al. Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah. Gastroenterology 2014 ; 147 : 814–821. [CrossRef] [PubMed] [Google Scholar]
  3. McLean MH, Dieguez D Jr, Miller LM, et al. Does the microbiota play a role in the pathogenesis of autoimmune diseases? Gut 2015 ; 64 : 332–341. [CrossRef] [PubMed] [Google Scholar]
  4. Sobhani I, Tap J, Roudot-Thoraval F, et al. Microbial dysbiosis in colorectal cancer (CRC) patients. PLoS One 2011 ; 6 : e16393. [CrossRef] [PubMed] [Google Scholar]
  5. Jobin C. Microbiome Un nouveau facteur de risque de cancer colorectal ? Med Sci (Paris) 2013 ; 29 : 582–585. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  6. Faivre J, Dancourt V, Lejeune C, et al. Reduction in cancer colorectal mortality by fecal occult blood screening in a French controlled study. Gastroenterology 2004 ; 126 : 1674–1680. [CrossRef] [PubMed] [Google Scholar]
  7. INCa. L’essentiel sur le test immunologique. http://www.e-cancer.fr/depistage/depistage-du-cancer-colorectal/espace-professionnels-de-sante/lessentiel-sur-le-test-immunologique. [Google Scholar]
  8. Moore WE, Moore LH. Intestinal floras of populations that have a high risk of colon cancer. Appl Environ Microbiol 1995 ; 61 : 3202–3207. [PubMed] [Google Scholar]
  9. Marchesi JR, Dutilh BE, Hall N, et al. Towards the 661 human colorectal cancer microbiome. PLoS One 2011 ; 6 : e20447. [CrossRef] [PubMed] [Google Scholar]
  10. Warren RL, Freeman DJ, Pleasance S, et al. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 2013 ; 1 : 16. [CrossRef] [PubMed] [Google Scholar]
  11. Sobhani I, Amiot A, Le Baleur Y, et al. Microbial dysbiosis and colon carcinogenesis: could colon cancer be considered a bacteria-related disease? Therap Adv Gastroenterol 2013 ; 6 : 215–229. [CrossRef] [PubMed] [Google Scholar]
  12. Keku TO, Dulal S, Deveaux A, et al. The gastrointestinal microbiota and colorectal cancer. Am J Physiol Gastrointest Liver Physiol 2015 ; 308 : G351–G363. [CrossRef] [PubMed] [Google Scholar]
  13. Zeller G, Tap J, Voigt AY, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol 2014 ; 10 : 766. [CrossRef] [PubMed] [Google Scholar]
  14. Amiot A, Mansour H, Baumgartner I, et al. The detection of methylated Wif-1 gene is more accurate for identifying advanced adenomas and colorectal cancer than faecal occult blood test. PLoS One 2014 ; 9 : e99233. [CrossRef] [PubMed] [Google Scholar]
  15. Roperch JP, Incitti R, Forbin S, et al. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer. BMC Cancer 2013 ; 13 : 566. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.